Benzinga · Mar 3, 2026
SO
NASDAQ · SOPH
SOPHiA GENETICS S.A.
Healthcare · Medical - Healthcare Information Services
$8.14
Down-$0.78 (-8.74%)
Updated Aug 30, 2026, 11:56 PM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 321.51M
- P/E ratio
- -4.39
- Dividend yield
- 0.00%
- 52-week range
- $4.28 – $8.98
- Volume
- 417.17K
- Avg. volume
- 114.15K
Price performance
SOPH price history
1M range · 0 trading sessions · Daily adjusted prices
SOPH does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest SOPH news
The latest Smart Investors Daily articles mentioning SOPH.
Stock researchCompany · Overview
SOPH research
Overview
Company profile and research snapshot.
Company profile
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $5.33
- Implied upside
- —
- Analysts
- 10
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 5, 2026 | BTIG | Buy | — |
| Jul 20, 2026 | HC Wainwright & Co. | Buy | — |
| Jun 15, 2026 | BTIG | Buy | — |
| May 6, 2026 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Mar 3, 2026
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript
ChartMill · Mar 3, 2026
SOPHiA GENETICS SA (NASDAQ:SOPH) Reports Mixed Q4 2025 Results with Revenue Beat and EPS Miss
SOPHiA GENETICS reports Q4 2025 revenue beat but wider-than-expected loss, highlighting growth in AI-driven genomic analysis as path to profitability continues.
SeekingAlpha · Mar 3, 2026
SOPHiA GENETICS SA 2025 Q4 - Results - Earnings Call Presentation
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
